Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 December 2021 | Story Leonie Bolleurs | Photo Supplied

Two students, Jenny Josefsson and Janie Swanepoel in the Faculty of the Humanities at the University of the Free State (UFS), graduated with joint degrees during the December graduation ceremonies. 

Josefsson received her degree from both the UFS and Radboud University in Nijmegen in the Netherlands, and Swanepoel was awarded her degree by the UFS and the University of Cologne, Germany. 

According to the Office for International Affairs (OIA) at the UFS – with a joint degree, the candidate receives an academic qualification from more than one institution at the same time. 

Zenzele Mdletshe from the OIA explains that a student will register at two different institutions at the same time, with the goal of obtaining one qualification. “Upon completion, the home institution will issue a joint degree certificate while the host institution will issue a degree supplement. For both Josefsson and Swanepoel, the UFS was the home institution.”

The UFS also awarded two joint degrees in 2020.

Social change, inequality, and land issues

Josefsson, who was born in Sweden, matriculated at Ljusdals Gymnasieskola in 1997. She obtained both her Environmental Science and Development Studies degree and her cum laude master’s degree in Environmental Science at Södertörn University. As an exchange student, she spent one semester in 2006 at the University of KwaZulu-Natal, and two years later started her career as an environmental consultant in Cape Town. 

She proceeded to do her PhD, and as part of her academic journey towards completing her doctoral degree, she joined a group of doctoral students from South Africa and the Netherlands, whose research fell under a project titled ‘Farm Dwellers, the Forgotten People? Conversions to Conservation in KwaZulu-Natal and the Eastern Cape’. The Dutch science-funding organisation, NWO-WOTRO Science for Global Development, funded the research. 

Based in the Department of Geography at the UFS, she continued with her research and started fieldwork in KwaZulu-Natal in 2013. During and after her fieldwork, she wrote several articles, which – together with an introductory chapter – formed the body of work submitted for her doctorate. 

Josefsson received her Doctor of Philosophy, specialising in Geography. The title of her study is: Battles over boundaries and belonging: violence, wilderness and spatial reconfigurations in the conversion of farm landscapes in KwaZulu-Natal, and highlights the ground-level politics of land issues. Her research is an important contribution to the wider debate around social change, inequality, and land issues in South Africa.

Her thesis was examined by the UFS according to South African examination procedures, and then by a body of examiners appointed by Radboud University. She defended her thesis during a Zoom session with Radboud University in October 2021.

Josefsson, who has worked on various projects in Southern Africa and South Asia, is currently working as a programme coordinator for a climate services project in the SADC region. 

Rethinking commercial ranching in rural Southern Africa

Completing school in Bloemfontein, Swanepoel obtained her BA at Stellenbosch University, and her BA Honours in Social Anthropology at the University of Cape Town. In 2013, she received her master’s degree in Social Anthropology at Stellenbosch University. 

Seven years later, she successfully submitted her PhD dissertation in Social Anthropology at the UFS. Her PhD forms part of a co-tutelage agreement with the University of Cologne.

Swanepoel, who is working in social compliance, received the Doctor of Philosophy with specialisation in Anthropology. The title of her dissertation is: In the land of the jackals: Postcolonial aridity in Southern Namibia. She investigates multispecies relations in a changing Namibian Boer community.

Her dissertation suggests the need to rethink commercial ranching in rural Southern Africa. “Given the glocal increase in aridity, this research shows the limitations of engaging with the decolonisation of land and the impact of climate change in ways that perpetuate the relation between nature and culture.”

She was invited to rework her dissertation into a book.

Advantages of joint degree

According to Mdletshe, there are several advantages to a joint degree. “The students involved in this programme have a chance of pursuing an international academic programme while enrolled at the UFS.”

He adds: “The students will also have a chance to be mentored and guided by supervisors from different institutions, bringing different perspectives. Such programmes will not only expose students to different lifestyles and cultures – as they will travel to the host institution from time to time – but it will also introduce them to different methods of teaching and learning.

He believes that with the input of international institutions, the joint degree will give students a competitive edge.

“We encourage students and academics who are interested in this programme to contact Kagiso Ngake (ngakekm@ufs.ac.za) or myself (mdletshezp@ufs.ac.za) in the Partnership Office at the Office for International Affairs,” says Mdletshe.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept